Literature DB >> 9923804

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.

N Nagasue1, H Kohno, M Tachibana, A Yamanoi, H Ohmori, O N El-Assal.   

Abstract

OBJECTIVE: To evaluate prognostic factors after resection of hepatocellular carcinoma (HCC) in patients with Child-Turcotte class B and C cirrhosis. SUMMARY BACKGROUND DATA: Although hepatic resection remains the mainstay in the treatment of HCC and can be performed with low morbidity and mortality rates in patients without cirrhosis, its role is poorly defined for patients with severe cirrhosis.
METHODS: From 1986 to 1996, partial hepatectomy was performed for HCC in 63 patients with Child-Turcotte class B (n = 46) and C (n = 17) cirrhosis. There were 46 men and 17 women, with an average age of 61.2 years (range 35 to 79 years). Associated conditions were diabetes mellitus in 45, esophageal varices in 32, severe hypersplenism in 26, cholelithiasis in 13, gastroduodenal ulcer in 6, and hiatal hernia, gastric lymphoma, splenic abscess, and pancreatic cyst each in 1. Concomitant surgical procedures were performed for most of these conditions.
RESULTS: Major complications occurred in 17 patients (27%), six (9.5%) of whom died within 1 month after surgery. The overall in-hospital death rate was 14.3%. Liver failure and intraabdominal sepsis were mostly fatal complications. The overall and disease-free survival rates, respectively, were 70.2% and 64.5% at 1 year, 43.5% and 23.8% at 3 years, and 21.4% and 14.9% at 5 years. Multivariate analysis with the Cox regression model revealed that favorable factors for survival were Child class B, no transcatheter arterial embolization before surgery, young age, and low alanine aminotransferase (ALT) level before surgery.
CONCLUSIONS: Hepatic resection can provide a favorable result in young patients with HCC complicating Child class B cirrhosis with low hepatitis activity, but transcatheter arterial embolization before surgery should be avoided in such patients.

Entities:  

Mesh:

Year:  1999        PMID: 9923804      PMCID: PMC1191612          DOI: 10.1097/00000658-199901000-00011

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  41 in total

1.  Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients.

Authors:  M Ebara; M Ohto; T Shinagawa; N Sugiura; K Kimura; S Matsutani; M Morita; H Saisho; Y Tsuchiya; K Okuda
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

2.  Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver.

Authors:  N Fujio; K Sakai; H Kinoshita; K Hirohashi; S Kubo; R Iwasa; K C Lee
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

3.  Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis.

Authors:  G Gozzetti; A Mazziotti; A Cavallari; R Bellusci; L Bolondi; W Grigioni; R Bragaglia; G L Grazi; E De Raffele
Journal:  Surg Gynecol Obstet       Date:  1988-06

4.  Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study.

Authors:  G Kleber; T Sauerbruch; H Ansari; G Paumgartner
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

Review 5.  Is liver transplantation justified for the treatment of hepatic malignancies?

Authors:  K M Olthoff; J M Millis; M H Rosove; L I Goldstein; K P Ramming; R W Busuttil
Journal:  Arch Surg       Date:  1990-10

6.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

7.  Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.

Authors:  L Barbara; G Benzi; S Gaiani; F Fusconi; G Zironi; S Siringo; A Rigamonti; C Barbara; W Grigioni; A Mazziotti
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

8.  Survival after hepatic resection for malignant tumours.

Authors:  A P Savage; R A Malt
Journal:  Br J Surg       Date:  1992-10       Impact factor: 6.939

9.  Primary treatment of hepatocellular carcinoma by arterial chemoembolization.

Authors:  H Bismuth; M Morino; D Sherlock; D Castaing; C Miglietta; P Cauquil; A Roche
Journal:  Am J Surg       Date:  1992-04       Impact factor: 2.565

10.  Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients.

Authors:  B Ringe; R Pichlmayr; C Wittekind; G Tusch
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

View more
  31 in total

1.  Comparative study of perioperative management of hepatic resection.

Authors:  K Akashi; S Mizuno; S Isaji
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

2.  Localized Hepatocellular Carcinoma.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

3.  A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma.

Authors:  Masaki Kaibori; Noboru Tanigawa; Shuji Kariya; Hiroki Ikeda; Yoshitsugu Nakahashi; Junko Hirohara; Chizu Koreeda; Toshihito Seki; Satoshi Sawada; Kazuichi Okazaki; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2012-01-24       Impact factor: 3.199

4.  Comparative study and systematic review of laparoscopic liver resection for hepatocellular carcinoma.

Authors:  Wei Qi Leong; Iyer Shridhar Ganpathi; Alfred Wei Chieh Kow; Krishnakumar Madhavan; Stephen Kin Yong Chang
Journal:  World J Hepatol       Date:  2015-11-28

5.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

6.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 7.  The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma--indication, technique and results.

Authors:  Till Herbold; Roger Wahba; Christopher Bangard; Münevver Demir; Uta Drebber; Dirk L Stippel
Journal:  Langenbecks Arch Surg       Date:  2012-10-24       Impact factor: 3.445

8.  Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study.

Authors:  E Berber; S Rogers; A Siperstein
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

9.  Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up.

Authors:  Naveen Ballem; Eren Berber; Tracy Pitt; Allan Siperstein
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 10.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  JAMA       Date:  2008-12-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.